Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
15m agoTimberland Bancorp Reports Second Fiscal Quarter Net Income of $7.1 Million
41m agoCPKC increases dividend by 17.5 percent
41m agoWaldencast announces conclusion of SEC investigation
42m agoNektar to Announce Financial Results for the First Quarter on Thursday, May 7, 2026, After Close of U.S.-Based Financial Markets
42m agoF5 to Host Analyst and Investor Meeting on May 28, 2026
Zevra Therapeutics Inc. logo

Zevra Therapeutics Inc.

About

Zevra Therapeutics Inc. (NASDAQ:ZVRA) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call
Mar 20 2026
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
Mar 16 2026
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
Mar 10 2026
GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
Mar 9 2026
Zevra Reports Fourth Quarter and Full Year 2025 Financial Results

Financials

Revenue
$106.47 M
Market Cap
$551.89 M
P/E Ratio
6.96
EPS
1.35

Community Chat

Ask AI

6ix6ixAIEvents